Qube Research & Technologies (QRT)’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
Other funds holding XPH
KWM
FCBT
EP
Qube Research & Technologies (QRT)'s XPH Position: Q2 2026 in Review
Qube Research & Technologies (QRT) increased its State Street SPDR S&P Pharmaceuticals ETF (XPH) stake by 53% in Q2 2026, buying an estimated $4.69K and bringing the position to 230 shares worth $15.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3249.
Qube Research & Technologies (QRT) first reported a position in XPH in Q2 2021 and has held it in 19 quarters since. The position peaked at $34.6K in Q4 2022. 93 funds tracked by Wall St. Rank hold XPH as of Q2 2026.
- Qube Research & Technologies (QRT) held 230 shares of State Street SPDR S&P Pharmaceuticals ETF worth $15.2K as of Q2 2026.
- Qube Research & Technologies (QRT) bought 80 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2026, an estimated $4.69K.
- State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #3249 holding.
- Qube Research & Technologies (QRT) first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2021 and has held it in 19 quarters since.
- Qube Research & Technologies (QRT)'s State Street SPDR S&P Pharmaceuticals ETF position peaked at $34.6K in Q4 2022.
- 93 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2026.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.